Navigation Links
Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
Date:2/8/2008

than 80 patients as a single agent and in combination therapy cancer studies, and as monotherapy in patients with HCV, have demonstrated a predictable and acceptable safety profile that is consistent with preclinical predictions," said Dr. Stopeck. "I look forward to helping to advance the clinical program for this novel approach to cancer therapy."

Bavituximab is believed to help mobilize the body's immune system to destroy the blood vessels needed for tumor growth and spread. Preclinical studies have shown that bavituximab's PS target is upregulated by radiation and chemotherapy, suggesting that anti-PS agents are good candidates for use as part of combination therapy regimens. The approach has demonstrated encouraging anti-tumor activity as part of combination therapy regimens in a number of solid tumor models.

"We are delighted that Dr. Stopeck is presenting early clinical data on bavituximab at this important scientific meeting," said Steven W. King, president and CEO of Peregrine. "As we move to assess bavituximab in Phase II efficacy trials, we are eager to share with the broader scientific and medical communities the growing body of data supporting the positive safety profile and signs of anti-tumor and anti-viral effects demonstrated by this exciting new class of drugs in both single agent and combination therapy studies."

In a Phase Ib pilot trial in advanced cancer patients, bavituximab plus chemotherapy appeared to have a safety profile consistent with chemotherapy alone and showed positive signs of clinical activity in a number of tumor types, achieving objective response or disease stabilization in 50% of the evaluable patients. Peregrine recently received regulatory approval to conduct three Phase II trials to study the anti-tumor effects of bavituximab in combination with chemotherapy. These include two breast cancer protocols and a non-small cell lung cancer (NSCLC) protocol. One of the breast cancer trials has begun enrolling p
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
2. IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a Phase I/II Clinical Trial in Treatment-Naive HIV-Infected Patients
3. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
4. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
5. Multiple Dose Clinical Trial of TorreyPines Therapeutics Tezampanel Demonstrates Compound is Safe and Well-Tolerated
6. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
7. PTC Therapeutics Announces Publication of Preclinical Data in PNAS
8. Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market
9. Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial
10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
11. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Pharmavite LLC announced that Timothy "Tim" Toll ... immediately. Toll recently served as Pharmavite,s executive vice president ... private label and sales administration in the ... Toll will expand his responsibilities to include international sales, ... appointment to chief customer officer is part of a ...
(Date:7/23/2014)... 2014 On Tuesday, July 1, 2014, ... in the 116 th Judicial District Court ... RegenLab USA, LLC ("Defendant") for ... through false and misleading actions, fraud, fraud-in-the-inducement, ... through libel, disparagement, defamation, misrepresentation, and violating ...
(Date:7/23/2014)... -- RT Oncology Services Corporation today announced that Craig ... directors. Mr. Mundie is currently senior advisor to the ... projects within the company and on technology strategy and ... officer. Mike Martin , president ... a visionary technology executive. His appointment is part of ...
Breaking Medicine Technology:Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
... --,Pharmacyclics, Inc. announced today multiple presentations and ... an oral presentation of Phase 3 SMART ... Radiation,Therapy) trial data. The presentations and publications ... American Society of Clinical Oncology,Annual Meeting (ASCO) ...
... Two New Studies Highlight Potential Benefit of ... /PRNewswire/ -- Stimulant drug abuse,remains an ongoing ... to treat Attention Deficit Hyperactivity Disorder,(ADHD). Data ... Meeting of,the American Psychiatric Association highlighted findings ...
Cached Medicine Technology:Pharmacyclics Announces Presentations and Published Abstracts on,Xcytrin at The 2007 American Society of Clinical Oncology Annual,Meeting 2New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 2New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 3New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 4New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 5
(Date:7/23/2014)... 23, 2014 Celebrating a decade of ... today announced the awarding of $1,070,000 in grants to ... in recognition of the Foundation’s 1,000th grant. , “The ... our tradition of supporting community-based organizations that are working ... life in the Garden State,” said Robert A. Marino, ...
(Date:7/23/2014)... a growing body of research suggesting a safe ... treating postmenopausal breast cancer, with fewer detrimental side ... anti-hormone therapies. The study will be published in ... Reproductive Biology and Endocrinology . , Breast cancer ... in the United States. Approximately 70% of breast ...
(Date:7/23/2014)... 23, 2014 Global Cardio Care, Inc., ... External Counterpulsation (EECP), is celebrating the 100th birthday ... at the health center. , Weber has been ... receiving ongoing EECP therapy since 1999, he no longer ... CEO of Global Cardio Care, introduced the Sara ...
(Date:7/23/2014)... The voice on the recording was low and ... news he was infected with the human immunodeficiency virus (HIV) that ... next thing you know I was on the floor flat on ... was hopeful when the recording ended less than 10 minutes later. ... . because it is just God setting you up for ...
(Date:7/23/2014)... WEDNESDAY, July 23, 2014 (HealthDay News) -- For patients ... antiretroviral therapy may help control both viruses, a small ... findings to improve treatment strategies for people with the ... suppression with antiretroviral medications plays an important role in ... infection," said study leader Dr. Kenneth Sherman, a professor ...
Breaking Medicine News(10 mins):Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3Health News:HIV Meds May Also Help Control Hepatitis C, Study Finds 2
... , , , , ANAHEIM, Calif., June ... entertainment, public health and justice professionals, and Drug Court graduates gathered ... and call for a Drug Court to be put within reach ... Court Professionals (NADCP) 15th Annual Training Conference. , , ...
... common cancers in China. Although the association between the ... the relation between smoking, alcohol drinking, family history of ... still remains uncertain. So it is important to investigate ... sporadic colorectal cancer. A research team led by ...
... Health Insurer Hires 200th Employee , , Momentum Builds ... Health Care Insurance Crisis , , AVENTURA, Fla., June ... health insurance benefit programs for the consumer market, today announced ... "Cinergy Health is a company with a clear mission -- ...
... ... & Public Relations® (BSAPR) a full-service, integrated strategic marketing services firm, today announced ... ... 2009 -- Blanchard Schaefer Advertising & Public Relations ® (BSAPR) a full-service, ...
... Thursday 11 June 2009: Undertaking a supervised exercise ... and physical function, reduce the need for daily ... depression and anxiety in people with rheumatoid arthritis ... at EULAR 2009, the Annual Congress of the ...
... STARTLING TRUTHS , , PALM COAST, Fla., June 11 ... photos are uploaded daily through digital networks such as Facebook and ... like acne have on the life of teens? Based on first ... social traits than if they had clear skin, according to results ...
Cached Medicine News:Health News:U.S. Drug Czar Addresses 2,500 Drug Court Professionals, Voices Strong Support for Expanding Drug Courts Throughout the Nation 2Health News:U.S. Drug Czar Addresses 2,500 Drug Court Professionals, Voices Strong Support for Expanding Drug Courts Throughout the Nation 3Health News:Cinergy Health Expands Staff in Face of Dramatic Growth 2Health News:Blanchard Schaefer Advertising & Public Relations Wins Healthcare Advertising Awards 2Health News:Blanchard Schaefer Advertising & Public Relations Wins Healthcare Advertising Awards 3Health News:Exercise improves functional and psycological ability and reduces steroid need in rheumatoid arthritis 2Health News:Photos: New Image Survey Reveals 'Perception Is Reality' When It Comes to Teenagers With Acne 2Health News:Photos: New Image Survey Reveals 'Perception Is Reality' When It Comes to Teenagers With Acne 3Health News:Photos: New Image Survey Reveals 'Perception Is Reality' When It Comes to Teenagers With Acne 4Health News:Photos: New Image Survey Reveals 'Perception Is Reality' When It Comes to Teenagers With Acne 5
West 2 periosteal elevators....
Alexander periosteal elevators....
Sedillot periosteal elevators....
Modified Freer periosteal elevator, #163, slight curve, 21 cm....
Medicine Products: